Moderna’s COVID-19 Vaccine Study in Adolescents Has Met its Primary Endpoints

In the study, which enrolled 3700 US participants ages 12 to less than 18 years, no cases of COVID-19 were found in participants who had received two doses of the Moderna COVID-19 vaccine.